1. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I (2002) J Clin Invest 110(12): 1859-68
    › Primary publication · 12488436 (PubMed) · PMC151648 (PubMed Central)
  2. The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall. Fazio S, Linton MF (2001) Am J Cardiol 88(2A): 12E-15E
    › Primary publication · 11473738 (PubMed)
  3. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. Ishiguro H, Yoshida H, Major AS, Zhu T, Babaev VR, Linton MF, Fazio S (2001) J Biol Chem 276(39): 36742-8
    › Primary publication · 11477092 (PubMed)
  4. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB (2001) Kidney Int 59(5): 1899-910
    › Primary publication · 11318962 (PubMed)
  5. Mouse models of hyperlipidemia and atherosclerosis. Fazio S, Linton MF (2001) Front Biosci : D515-25
    › Primary publication · 11229870 (PubMed)
  6. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF (2001) Nat Med 7(6): 699-705
    › Primary publication · 11385507 (PubMed) · PMC4027052 (PubMed Central)
  7. Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice. Yoshida H, Hasty AH, Major AS, Ishiguro H, Su YR, Gleaves LA, Babaev VR, Linton MF, Fazio S (2001) Circulation 104(23): 2820-5
    › Primary publication · 11733401 (PubMed)
  8. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S (2001) Arterioscler Thromb Vasc Biol 21(11): 1790-5
    › Primary publication · 11701467 (PubMed)
  9. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. Fazio S, Major AS, Swift LL, Gleaves LA, Accad M, Linton MF, Farese RV (2001) J Clin Invest 107(2): 163-71
    › Primary publication · 11160132 (PubMed) · PMC198874 (PubMed Central)
  10. Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low" Fazio S, Linton MF (2001) Curr Control Trials Cardiovasc Med 2(1): 8-11
    › Primary publication · 11806766 (PubMed) · PMC59646 (PubMed Central)